The Path wants to be the AI therapy app that actually won't hurt you

AI therapy startup The Path is making a bold opening move: its model scored 95 out of 100 on Vera-MH, the mental health AI safety benchmark, while the best consumer bots barely reach 65. That 30-point gap isn't a marketing number — it's a direct argument for why purpose-built clinical AI should replace the generic chatbots people are already turning to in crisis moments.

How we got here

For the past few years, general-purpose AI assistants have been quietly filling a void in mental health care — not because anyone planned it that way, but because access to real therapists is expensive, slow, and unevenly distributed. The problem is that tools like standard consumer chatbots were never designed to handle suicidal ideation or dissociative episodes safely. Vera-MH was created specifically to measure how AI systems perform in those high-stakes situations, filling a gap that neither the tech industry nor regulators had properly addressed.

The team, the numbers, the claim

The Path was co-founded by alumni from Calm — one of the most-downloaded wellness apps globally — and has Tony Robbins involved, the well-known life coach and self-help author. The founding team knows the wellness consumer market from the inside. The core data points:

• 95/100 on the Vera-MH benchmark for The Path's proprietary model
• Top score of 65 across existing consumer bots
• A 30-point safety gap that represents significant clinical risk in real-world use

Vera-MH doesn't test for polite conversation — it evaluates how a system responds when someone expresses suicidal thoughts, panic attacks, or acute psychological distress. Failing that test isn't a quirk. It's a design problem.

What this actually means

The Path's strategy is sharp: instead of competing on features or price, it's positioning itself as the clinically responsible option in a market that desperately needs one. The real target customers aren't individual users — they're employers, insurers, and health systems that carry legal and reputational liability when their mental health tools cause harm. The honest caveat is that a benchmark score can be gamed if a model is trained specifically to pass it. Independent audits and real-world outcome data will matter a lot more than a number on a leaderboard.

What happens next

If The Path gains traction, Vera-MH could quickly become a de facto industry standard — one that other mental health AI startups will have to meet to access the more lucrative B2B healthcare channels. That would likely trigger market consolidation, pushing out wellness apps that never invested in clinical safety infrastructure. On the regulatory side, concrete benchmark data like this gives policymakers a tool they've been lacking: a way to set AI mental health standards without simply banning innovation outright.

The real test isn't the benchmark score — it's whether licensed therapists and psychiatrists will ever trust an AI enough to recommend it to their patients.

Source: TechCrunch